Radius Health, a biotech developing treatments to restore bone density in osteoporosis patients, filed on Wednesday with the SEC to raise up to $86 million in an initial public offering. The Cambridge, MA-based company, which was founded in 2003, plans to list on the NASDAQ under the symbol RDUS. Jefferies and Cowen & Company are the joint bookrunners on the deal. No pricing terms were disclosed.
